YD Bio YDES
NASDAQ YDES
$2.63 +0.00 (+0.19%)
As of: Sep 22, 2026 · 11:58 AM EDT

YD Bio (YDES) Cash & Equivalents Growth (1y) (2025 - 2026)

Analysis

YD Bio (YDES) Cash & Equivalents Growth (1y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 74.25%
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn -38.20%
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 23.56%
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 23.05%
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn 34.71%
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn 71.81%
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 53.39%
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn -53.42%
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn -
10 YD Bio 225.82 Mn 223.16 Mn - 466.96%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 466.96%
Dec 31, 2025 91.80%
API Access

YD Bio Cash & Equivalents Growth (1y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents-growth-1y&ticker=YDES&period=max&api_key=YOUR_API_KEY